InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Discover the full record of transactions filed by MULLEN JAMES C, Chairman & CEO. Insider active across 2 companies, notably Thermo Fisher Scientific INC.. In total, 11 reports have been published. Total volume traded: €1.8m. The latest transaction was disclosed on 18 May 2022 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations11 total
0369 shares0
Common Stock
SEC:0001127602-22-015287:0·
€432,56818,252 shares@ €23.69970.22% mcap48.9% of flow
Common Stock
SEC:0001179110-22-000112·
€432,56818,252 shares@ €23.69970.22% mcap24.4% of flow
Common Stock
SEC:0001179110-22-000112:0·
036,477 shares0
Common Stock
SEC:0001179110-21-011223·
036,477 shares0
Common Stock
SEC:0001179110-21-011223:0·
€452,07513,805 shares@ €32.74720.23% mcap51.1% of flow
Common Stock
SEC:0001179110-21-009557·
€452,07513,805 shares@ €32.74720.23% mcap25.6% of flow
Common Stock
SEC:0001179110-21-009557:0·
036,478 shares0
Common Stock
SEC:0001179110-21-009149·
036,478 shares0
Common Stock
SEC:0001179110-21-009149:0·
0438 shares0
Common Stock
SEC:0001127602-21-017562·
0438 shares0
Common Stock
SEC:0001127602-21-017562:0·
11 of 11 declarations
About MULLEN JAMES C
James C. Mullen is the Chairman & CEO of Thermo Fisher Scientific Inc. and Editas Medicine, Inc. He oversees the strategic operations and overall direction of these companies. With extensive experience in the industry, Mullen is recognized for his leadership in developing innovative solutions and advanced technologies. His role also involves managing stakeholder relationships and promoting sustainable growth within his organizations.
